SMTL ID : 2c6o.1

Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x 4SP: O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE(Non-covalent)

4SP.1: 17 residues within 4Å: Chain A: I.10, G.13, V.18, A.31, K.33, V.64, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, Q.131, L.134, D.145 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:F.82, A:Q.131, A:L.134 Hydrogen bonds: A:E.81, A:L.83, A:L.83, A:D.86, A:D.86, A:K.89

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Richardson, C.M. et al., Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR. Bioorg. Med. Chem. Lett. (2006)

Release Date

2005-12-07

Peptides

CELL DIVISION PROTEIN KINASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CELL DIVISION PROTEIN KINASE 2

Related Entries With Identical Sequence